Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium

Brain Research Bulletin

Volumn 55, Issue 5, 2001, Pages 651-659

  Knable, Michael B ^a   Torrey, E Fuller ^a,b   Webster, Maree J ^b   Bartko, John J ^a  

^a Stanley Medical Research Institute   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Bipolar disorder; Depression; Neuropathology; Postmortem; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR; HORMONE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR; NITRIC OXIDE; PHOSPHOLIPASE C; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; DEPRESSION; FEMALE; HEMISPHERE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MULTIVARIATE ANALYSIS; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTRANSMISSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ADULT; AGED; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CALCIUM CHANNELS; CELL ADHESION MOLECULES, NEURONAL; DEPRESSIVE DISORDER, MAJOR; ELECTRON TRANSPORT COMPLEX IV; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SCHIZOPHRENIA; SERINE ENDOPEPTIDASES; SUBSTANCE-RELATED DISORDERS; TISSUE BANKS;

EID: 0035878181     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00521-4     Document Type: Article

References (41)

1. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
2. Antidepressant drug exposure increases tyrosine kinase receptor B mRNA levels in major depressive disorder. Prog. Neuropsychopharmacol
3. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania
4. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
5. Nitric oxide-mediated mitochondrial damage in the brain; Mechanisms and implications for neurodegenerative diseases
6. Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion
7. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder
8. Identification of nuclear orphan receptors as regulators of expression of a neurotransmitter receptor gene
9. Abnormalities of Wnt signaling in schizophrenia-Evidence for neurodevelopmental abnormality
10. Nitric oxide; Role in neurotoxicity
11. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
12. Glutamate, nitric oxide and cell-cell signalling in the nervous system
13. Functional and anatomical aspects of prefrontal pathology in schizophrenia
14. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder; A post mortem brain study
15. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
16. A decrease of reelin expression as a putative vulnerability factor in schizophrenia
17. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain
18. Dopamine, the prefrontal cortex and schizophrenia
19. Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients
20. Changing concepts on the role of glia
21. Chandelier cells; Shedding light on altered cortical circuitry in schizophrenia
22. Heterodimerization between members of the nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation
23. Protein kinase C signaling in the brain; Molecular transduction of mood stabilization in the treatment of manic-depressive illness
24. Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine
25. Increased expression of Wnt-1 in schizophrenic brains
26. Glutamate receptor dysfunction and schizophrenia
27. Glial reduction in the subgenual prefrontal cortex in mood disorders
28. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
29. The neuroendocrinology of stress and aging; The glucocorticoid cascade hypothesis
30. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia
31. Heterogenous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy; A laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique
32. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decrease in frontal cortex of 'neuroleptic-free' schizophrenics; Evidence on reversible up-regulation by typical neuroleptics
33. The Stanley Foundation Brain Collection and Neuropathology Consortium
34. Decrease glutamic acid decarboxylase 67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia
35. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder
36. Dopamine neuron agenesis in Nurr1-deficient mice